Virus-like particles induce robust human T-helper cell responses. by Braun, M, Jandus, C, Maurer, P, Hammann-Haenni, A, Schwarz, K, Bachmann, M, Speiser, D, Romero, P

Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. by Klimek, L, Willers, J, Hammann-Haenni, A, Pfaar, O, Stocker, H, Mueller, P, Renner, W, Bachmann, M

The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. by Beeh, K, Kanniess, F, Wagner, F, Schilder, C, Naudts, I, Hammann-Haenni, A, Willers, J, Stocker, H, Mueller, P, Bachmann, M, Renner, W

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients. by Goldinger, S, Dummer, R, Baumgaertner, P, Mihic-Probst, D, Schwarz, K, Hammann-Haenni, A, Willers, J, Geldhof, C, Prior, J, Kündig, T, Michielin, O, Bachmann, M, Speiser, D